Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: A population-based cohort study

Chih Shin Lin, Charlene Lin, Shih Feng Weng, Shih Wei Lin, Yong-Song Lin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: HIV-related immunosuppression has been associated with the development of AIDS-defining malignancies. We examined the overall survival of HIV-infected patients who developed cancer. Design: A retrospective cohort study. Methods: Using the Taiwan Longitudinal Health Insurance Database, we compared patients diagnosed with HIV (n= 9918) between January 1, 2002, and December 31, 2007 with age-matched controls (n= 99,180). Each patient was followed until the end of 2009 (least 2 years after the initial HIV diagnosis) to evaluate the incidence of malignancies. Results: The risk of overall malignancies in the HIV-infected cohort was 1.88 times higher than the risk of a first malignancy in the age-matched non-HIV infected cohort (incidence rate ratio [IRR]) = 2.05, p<0.0001). The diagnosis of a malignancy was negatively correlated with survival in the HIV-infected cohort (p<0.0011), and HIV infection had a synergistic effect on the survival of patients with malignancies compared with the non-HIV infected cohort, all of who had been newly diagnosed with cancer (p<0.0001). However, the difference in the risk of developing nasopharyngeal carcinoma (NPC), a highly prevalent malignancy in Taiwan, between the two cohorts was not significant (IRR = 0.22, 95% CI = 0.03-1.65). Conclusions: The risk of cancer in HIV-infected patients in Taiwan has increased significantly in the era of highly active antiretroviral therapy. A history of HIV significantly affected the survival of the patients in our study cohort after they developed cancer. Evidence level: 2B.

Original languageEnglish
Pages (from-to)719-724
Number of pages6
JournalCancer Epidemiology
Volume37
Issue number5
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Highly Active Antiretroviral Therapy
Taiwan
Acquired Immunodeficiency Syndrome
Cohort Studies
HIV
Survival
Population
Neoplasms
Incidence
Health Insurance
Immunosuppression
HIV Infections
Retrospective Studies
Databases

Keywords

  • Cancer survival
  • Head and neck malignancy
  • HIV/AIDS
  • Nasopharyngeal carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Epidemiology

Cite this

Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan : A population-based cohort study. / Lin, Chih Shin; Lin, Charlene; Weng, Shih Feng; Lin, Shih Wei; Lin, Yong-Song.

In: Cancer Epidemiology, Vol. 37, No. 5, 10.2013, p. 719-724.

Research output: Contribution to journalArticle

Lin, Chih Shin ; Lin, Charlene ; Weng, Shih Feng ; Lin, Shih Wei ; Lin, Yong-Song. / Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan : A population-based cohort study. In: Cancer Epidemiology. 2013 ; Vol. 37, No. 5. pp. 719-724.
@article{6676d365df944beb844a3cf9574666c5,
title = "Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: A population-based cohort study",
abstract = "Objectives: HIV-related immunosuppression has been associated with the development of AIDS-defining malignancies. We examined the overall survival of HIV-infected patients who developed cancer. Design: A retrospective cohort study. Methods: Using the Taiwan Longitudinal Health Insurance Database, we compared patients diagnosed with HIV (n= 9918) between January 1, 2002, and December 31, 2007 with age-matched controls (n= 99,180). Each patient was followed until the end of 2009 (least 2 years after the initial HIV diagnosis) to evaluate the incidence of malignancies. Results: The risk of overall malignancies in the HIV-infected cohort was 1.88 times higher than the risk of a first malignancy in the age-matched non-HIV infected cohort (incidence rate ratio [IRR]) = 2.05, p<0.0001). The diagnosis of a malignancy was negatively correlated with survival in the HIV-infected cohort (p<0.0011), and HIV infection had a synergistic effect on the survival of patients with malignancies compared with the non-HIV infected cohort, all of who had been newly diagnosed with cancer (p<0.0001). However, the difference in the risk of developing nasopharyngeal carcinoma (NPC), a highly prevalent malignancy in Taiwan, between the two cohorts was not significant (IRR = 0.22, 95{\%} CI = 0.03-1.65). Conclusions: The risk of cancer in HIV-infected patients in Taiwan has increased significantly in the era of highly active antiretroviral therapy. A history of HIV significantly affected the survival of the patients in our study cohort after they developed cancer. Evidence level: 2B.",
keywords = "Cancer survival, Head and neck malignancy, HIV/AIDS, Nasopharyngeal carcinoma",
author = "Lin, {Chih Shin} and Charlene Lin and Weng, {Shih Feng} and Lin, {Shih Wei} and Yong-Song Lin",
year = "2013",
month = "10",
doi = "10.1016/j.canep.2013.05.005",
language = "English",
volume = "37",
pages = "719--724",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan

T2 - A population-based cohort study

AU - Lin, Chih Shin

AU - Lin, Charlene

AU - Weng, Shih Feng

AU - Lin, Shih Wei

AU - Lin, Yong-Song

PY - 2013/10

Y1 - 2013/10

N2 - Objectives: HIV-related immunosuppression has been associated with the development of AIDS-defining malignancies. We examined the overall survival of HIV-infected patients who developed cancer. Design: A retrospective cohort study. Methods: Using the Taiwan Longitudinal Health Insurance Database, we compared patients diagnosed with HIV (n= 9918) between January 1, 2002, and December 31, 2007 with age-matched controls (n= 99,180). Each patient was followed until the end of 2009 (least 2 years after the initial HIV diagnosis) to evaluate the incidence of malignancies. Results: The risk of overall malignancies in the HIV-infected cohort was 1.88 times higher than the risk of a first malignancy in the age-matched non-HIV infected cohort (incidence rate ratio [IRR]) = 2.05, p<0.0001). The diagnosis of a malignancy was negatively correlated with survival in the HIV-infected cohort (p<0.0011), and HIV infection had a synergistic effect on the survival of patients with malignancies compared with the non-HIV infected cohort, all of who had been newly diagnosed with cancer (p<0.0001). However, the difference in the risk of developing nasopharyngeal carcinoma (NPC), a highly prevalent malignancy in Taiwan, between the two cohorts was not significant (IRR = 0.22, 95% CI = 0.03-1.65). Conclusions: The risk of cancer in HIV-infected patients in Taiwan has increased significantly in the era of highly active antiretroviral therapy. A history of HIV significantly affected the survival of the patients in our study cohort after they developed cancer. Evidence level: 2B.

AB - Objectives: HIV-related immunosuppression has been associated with the development of AIDS-defining malignancies. We examined the overall survival of HIV-infected patients who developed cancer. Design: A retrospective cohort study. Methods: Using the Taiwan Longitudinal Health Insurance Database, we compared patients diagnosed with HIV (n= 9918) between January 1, 2002, and December 31, 2007 with age-matched controls (n= 99,180). Each patient was followed until the end of 2009 (least 2 years after the initial HIV diagnosis) to evaluate the incidence of malignancies. Results: The risk of overall malignancies in the HIV-infected cohort was 1.88 times higher than the risk of a first malignancy in the age-matched non-HIV infected cohort (incidence rate ratio [IRR]) = 2.05, p<0.0001). The diagnosis of a malignancy was negatively correlated with survival in the HIV-infected cohort (p<0.0011), and HIV infection had a synergistic effect on the survival of patients with malignancies compared with the non-HIV infected cohort, all of who had been newly diagnosed with cancer (p<0.0001). However, the difference in the risk of developing nasopharyngeal carcinoma (NPC), a highly prevalent malignancy in Taiwan, between the two cohorts was not significant (IRR = 0.22, 95% CI = 0.03-1.65). Conclusions: The risk of cancer in HIV-infected patients in Taiwan has increased significantly in the era of highly active antiretroviral therapy. A history of HIV significantly affected the survival of the patients in our study cohort after they developed cancer. Evidence level: 2B.

KW - Cancer survival

KW - Head and neck malignancy

KW - HIV/AIDS

KW - Nasopharyngeal carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84884150691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884150691&partnerID=8YFLogxK

U2 - 10.1016/j.canep.2013.05.005

DO - 10.1016/j.canep.2013.05.005

M3 - Article

C2 - 23770024

AN - SCOPUS:84884150691

VL - 37

SP - 719

EP - 724

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 5

ER -